Degrader-Antibody Conjugates: an emerging novel drug modality to address undruggable targets
STUTTGART, Germany I September 04, 2024 I La Merie Publishing released its newest report with a landscape description and analysis…
2023 Global Biologics Sales exceeding US$ 300 bln for the first time
The report covers 2023 sales data of innovator therapeutic antibodies and proteins, biosimilars and the novel biologic drug modalities gene…
Sales of Therapeutic Antibodies and Proteins in 2022 close to US$ 300 bln with Antibodies contributing more than 80%
BARCELONA, Spain I March 08, 2023 I La Merie Publishing released the 17th edition of its report series about sales…
Chimeric Antigen Receptor Macrophages (CAR-M): an emerging technology with promise to improve efficacy and safety of tumor immunotherapy
BARCELONA, Spain I February 07, 2023 I La Merie Publishing released today its newest report entitled “CAR-M Industry Landscape Analysis:…
Emerging RNA-Targeted Drug Modalities Open the Door for Novel Treatments
BARCELONA, Spain I November 13, 2022 I La Merie Publishing released today its newest report entitled “RNA-Targeted Novel Drug Modalities…
Compelling novel cancer targets with promise of low on-target, off-tumor toxicity
BARCELONA, Spain I July 6, 2022 I La Merie Publishing released today a report bundle entitled “Claudin 6, Cadherin 17,…
GPRC5D-Targeted drug modalities: a chance for cure of multiple myeloma?
BARCELONA, Spain I July 1, 2022 I La Merie Publishing released today its newest report entitled “GPRC5D-Targeted Therapy: Target Expression…
ROR1-Targeting provides opportunities for drug modalities with enhanced effector function
BARCELONA, Spain I June17, 2022 I La Merie Publishing released today its newest report entitled “ROR1-Targeted Therapy: Target Expression Profile,…
Cadherin 17-Targeted Novel Drug Modalities: a Target and Pipeline Review
BARCELONA, Spain I May 20, 2022 I La Merie Publishing released today its newest report entitled “Cadherin 17: A target…
Claudin 6: A compelling target to be addressed by effector-enhanced drug modalities
BARCELONA, Spain I May 13, 2022 I La Merie Publishing released today its newest report entitled “Claudin 6: A target…